Correlation Between Capricor Therapeutics and Merck

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Capricor Therapeutics and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capricor Therapeutics and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capricor Therapeutics and Merck Company, you can compare the effects of market volatilities on Capricor Therapeutics and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capricor Therapeutics with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capricor Therapeutics and Merck.

Diversification Opportunities for Capricor Therapeutics and Merck

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Capricor and Merck is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Capricor Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capricor Therapeutics are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Capricor Therapeutics i.e., Capricor Therapeutics and Merck go up and down completely randomly.

Pair Corralation between Capricor Therapeutics and Merck

Given the investment horizon of 90 days Capricor Therapeutics is expected to generate 5.09 times more return on investment than Merck. However, Capricor Therapeutics is 5.09 times more volatile than Merck Company. It trades about 0.09 of its potential returns per unit of risk. Merck Company is currently generating about -0.02 per unit of risk. If you would invest  390.00  in Capricor Therapeutics on August 29, 2024 and sell it today you would earn a total of  1,516  from holding Capricor Therapeutics or generate 388.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Capricor Therapeutics  vs.  Merck Company

 Performance 
       Timeline  
Capricor Therapeutics 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Capricor Therapeutics and Merck Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Capricor Therapeutics and Merck

The main advantage of trading using opposite Capricor Therapeutics and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capricor Therapeutics position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.
The idea behind Capricor Therapeutics and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals